Sanlayan, Klea .
HRN: 19-83-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFTRIAXONE 1G (VIAL)
12/26/2022
01/02/2023
IV
1G
Q24
T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes